Superficial temporal artery retrograde access for the treatment of chronic subdural hematomas.

IF 3 2区 医学 Q2 CLINICAL NEUROLOGY
Akshal S Patel, Yince Loh, Luke L Jouppi, Radwan Takroni, Daniel C Norvell, Stepan Capek, Nicolas M Caffes, Majid Aljoghaiman, Aaron J Gustin, Aws A Alawi, Zane A Tymchak, Cameron G McDougall, Stephen J Monteith
{"title":"Superficial temporal artery retrograde access for the treatment of chronic subdural hematomas.","authors":"Akshal S Patel, Yince Loh, Luke L Jouppi, Radwan Takroni, Daniel C Norvell, Stepan Capek, Nicolas M Caffes, Majid Aljoghaiman, Aaron J Gustin, Aws A Alawi, Zane A Tymchak, Cameron G McDougall, Stephen J Monteith","doi":"10.3171/2025.7.FOCUS25539","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Middle meningeal artery (MMA) embolization for chronic subdural hematoma (cSDH) has ushered in a treatment paradigm shift. The objective of this study was to determine whether the superficial temporal artery (STA) could be used consistently and just as effectively compared to conventional femoral and radial artery access.</p><p><strong>Methods: </strong>The authors retrospectively reviewed a series of consecutive cases from January 1, 2024, to February 28, 2025, where the STA was used to treat cSDH. The 90-day readmission, retreatment, and death rates were collected and compared against a set of internal comparison cases that underwent similar treatment, though via femoral or radial artery puncture.</p><p><strong>Results: </strong>The study included 40 patients with STA retrograde (STAR) access and 50 patients who had traditional transfemoral or radial artery approaches. In the STA group, there was significantly reduced radiation exposure (p < 0.001) and less contrast administration (p < 0.001). There were no differences between the groups in terms of the 90-day readmission (p = 0.82), retreatment (p = 0.93), or death rates (p = 0.42). One access site complication was observed after a transfemoral intervention.</p><p><strong>Conclusions: </strong>STAR access is an alternative for MMA embolization in cSDH. This innovative approach can potentially rival the results achieved by traditional techniques.</p>","PeriodicalId":19187,"journal":{"name":"Neurosurgical focus","volume":"59 4","pages":"E11"},"PeriodicalIF":3.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurosurgical focus","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3171/2025.7.FOCUS25539","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Middle meningeal artery (MMA) embolization for chronic subdural hematoma (cSDH) has ushered in a treatment paradigm shift. The objective of this study was to determine whether the superficial temporal artery (STA) could be used consistently and just as effectively compared to conventional femoral and radial artery access.

Methods: The authors retrospectively reviewed a series of consecutive cases from January 1, 2024, to February 28, 2025, where the STA was used to treat cSDH. The 90-day readmission, retreatment, and death rates were collected and compared against a set of internal comparison cases that underwent similar treatment, though via femoral or radial artery puncture.

Results: The study included 40 patients with STA retrograde (STAR) access and 50 patients who had traditional transfemoral or radial artery approaches. In the STA group, there was significantly reduced radiation exposure (p < 0.001) and less contrast administration (p < 0.001). There were no differences between the groups in terms of the 90-day readmission (p = 0.82), retreatment (p = 0.93), or death rates (p = 0.42). One access site complication was observed after a transfemoral intervention.

Conclusions: STAR access is an alternative for MMA embolization in cSDH. This innovative approach can potentially rival the results achieved by traditional techniques.

颞浅动脉逆行入路治疗慢性硬膜下血肿。
目的:脑膜中动脉(MMA)栓塞治疗慢性硬膜下血肿(cSDH)已经迎来了治疗模式的转变。本研究的目的是确定与传统的股动脉和桡动脉通道相比,颞浅动脉(STA)是否可以持续有效地使用。方法:回顾性分析2024年1月1日至2025年2月28日连续使用STA治疗cSDH的一系列病例。收集90天的再入院、再治疗和死亡率,并与一组内部比较病例进行比较,这些病例接受了类似的治疗,但通过股动脉或桡动脉穿刺。结果:该研究包括40例STA逆行(STAR)入路患者和50例传统经股动脉或桡动脉入路患者。STA组的辐射暴露明显减少(p < 0.001),对比剂剂量明显减少(p < 0.001)。在90天再入院(p = 0.82)、再治疗(p = 0.93)或死亡率(p = 0.42)方面,两组间无差异。经股动脉介入治疗后出现1例通路并发症。结论:STAR通道是cSDH中MMA栓塞的替代方案。这种创新的方法有可能与传统技术取得的结果相媲美。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurosurgical focus
Neurosurgical focus CLINICAL NEUROLOGY-SURGERY
CiteScore
6.30
自引率
0.00%
发文量
261
审稿时长
3 months
期刊介绍: Information not localized
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信